Inactive Instrument
Capstone Therapeutics Corp Stock Other OTC
Stocks
US14068E1091
Construction Materials
| Market Cap | 3.17M 2.78M 2.56M 2.4M 4.5M 299M 4.59M 30.78M 11.91M 148M 11.9M 11.64M 512M | P/E 2026 * |
4.18x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 3.17M 2.78M 2.56M 2.4M 4.5M 299M 4.59M 30.78M 11.91M 148M 11.9M 11.64M 512M | EV / Sales 2026 * |
0.04x | EV / Sales 2027 * | - |
| Free-Float |
57.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +11.54% |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Lipman
CEO | Chief Executive Officer | 47 | 02/12/2024 |
Edward Schultz
DFI | Director of Finance/CFO | 42 | 25/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jock Holliman
CHM | Chairman | 73 | 05/04/2006 |
Michael Toporek
CHM | Chairman | 62 | - |
Matthew Lipman
BRD | Director/Board Member | 47 | 14/07/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +11.54% | -.--% | - | - | 3.17M | ||
| 0.00% | -10.09% | +516.49% | +374.19% | 2.52B | ||
| +1.72% | +3.62% | +18.72% | +88.75% | 1.3B | ||
| +6.92% | -1.61% | -16.67% | +36.97% | 951M | ||
| -0.85% | 0.00% | +1.74% | -31.93% | 594M | ||
| -3.74% | -13.46% | -17.25% | -2.41% | 419M | ||
| 0.00% | -4.37% | +19.78% | +43.88% | 231M | ||
| -1.92% | -0.72% | - | - | 191M | ||
| +0.45% | +0.11% | +9.50% | -2.81% | 177M | ||
| 0.00% | -6.32% | +128.21% | +385.45% | 170M | ||
| Average | +1.41% | -4.08% | +82.56% | +111.51% | 727.7M | |
| Weighted average by Cap. | +0.99% | -4.29% | +209.46% | +180.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 72.11M 63.23M 58.28M 54.56M 102M 6.8B 104M 701M 271M 3.36B 271M 265M 11.66B | - |
| Net income | 687K 602K 555K 520K 975K 64.81M 995K 6.67M 2.58M 32.03M 2.58M 2.52M 111M | - |
| Net Debt | - | - |
Employees
-
Sector
Construction Materials
















